US Patent Issued to Alpha Cognition on Feb. 17 for "Dosage regimens for benzgalantamine" (Canadian, American Inventors)

ALEXANDRIA, Va., Feb. 17 -- United States Patent no. 12,551,491, issued on Feb. 17, was assigned to Alpha Cognition Inc. (Vancouver, Canada).

"Dosage regimens for benzgalantamine" was invented by Michael McFadden (Frisco, Texas) and Denis G. Kay (Stanhope, Canada).

According to the abstract* released by the U.S. Patent & Trademark Office: "A method of effectively reducing the pharmaceutical load of galantamine relative to oral administration of galantamine or a method of effectively administering galantamine in a subject in need of galantamine therapy for the treatment of mild to moderate dementia of the Alzheimer's type, the methods including orally administering a dosage form of benzgalantamine gluconate according to the following dosag...